Full Press Release Details
Zymeworks To Host Fourth Quarter And Full Year 2022 Results Conference Call.
ZYME
Zymeworks To Host Fourth Quarter And Full Year 2022 Results Conference Call
Key Takeaway: Zymeworks To Host Fourth Quarter And Full Year 2022 Results Conference Call
Price reaction · baseline $8.62 (2023-02-17 close) · hit after-hours · clean, no other ZYME news in the window
day 0 close · peak
-0.6%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+23%
120-day peak, hindsight
Typical move
5.4%
average across 7 past catalysts
Cash runway
~35 mo
Minimal dilution risk
Lead asset
ZW49
Phase 1 · HER2-expressing Cancers